tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OVID Stock Latest News

Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
Press ReleasesOvid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
1d ago
OVID
Ovid Therapeutics reports Q1 EPS (17c), consensus (22c)
PremiumThe Fly
Ovid Therapeutics reports Q1 EPS (17c), consensus (22c)
1d ago
OVID
Ovid Therapeutics price target lowered to $3.50 from $4 at Citi
PremiumThe Fly
Ovid Therapeutics price target lowered to $3.50 from $4 at Citi
8d ago
OVID
Ovid Therapeutics initiated with a Buy at B. Riley
PremiumThe Fly
Ovid Therapeutics initiated with a Buy at B. Riley
15d ago
OVID
Ovid Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Ovid Therapeutics initiated with a Buy at H.C. Wainwright
16d ago
OVID
Krispy Kreme upgraded, Altice USA downgraded: Wall Street’s top analyst calls
PremiumThe FlyKrispy Kreme upgraded, Altice USA downgraded: Wall Street’s top analyst calls
1M ago
AXP
CNK
Ovid initiated with Outperform on ‘unique’ assets at Wedbush
PremiumThe Fly
Ovid initiated with Outperform on ‘unique’ assets at Wedbush
1M ago
OVID
Ovid Therapeutics initiated with an Outperform at Wedbush
PremiumThe Fly
Ovid Therapeutics initiated with an Outperform at Wedbush
1M ago
OVID
Marinus Comments on patent challenge by Ovid Therapeutics
PremiumThe Fly
Marinus Comments on patent challenge by Ovid Therapeutics
2M ago
MRNS
OVID
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
2M ago
OVID
Ovid Therapeutics reports Q4 EPS (22c), consensus (5c)
PremiumThe Fly
Ovid Therapeutics reports Q4 EPS (22c), consensus (5c)
2M ago
OVID
Ovid Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Ovid Therapeutics management to meet with Oppenheimer
3M ago
OVID
Ovid Therapeutics management to meet with Oppenheimer
PremiumThe FlyOvid Therapeutics management to meet with Oppenheimer
3M ago
OVID
Ovid Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Ovid Therapeutics management to meet with Oppenheimer
3M ago
OVID
Ovid Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Ovid Therapeutics management to meet with Oppenheimer
3M ago
OVID
Ovid Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Ovid Therapeutics management to meet with Oppenheimer
3M ago
OVID
Ovid Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Ovid Therapeutics management to meet with Oppenheimer
3M ago
OVID
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
3M ago
OVID
Ovid Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Ovid Therapeutics management to meet with Oppenheimer
3M ago
OVID
Ovid Therapeutics initiated with a Buy at BTIG
PremiumThe FlyOvid Therapeutics initiated with a Buy at BTIG
5M ago
OVID
Ovid Therapeutics files $250M mixed securities shelf
PremiumThe Fly
Ovid Therapeutics files $250M mixed securities shelf
6M ago
OVID
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
PremiumPress Releases
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
6M ago
OVID

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >